Detalles de la búsqueda
1.
Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide.
J Infect Dis;
228(7): 919-925, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37526315
2.
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
J Antimicrob Chemother;
78(11): 2696-2701, 2023 11 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37725999
3.
Detecting anal human papillomavirus infection in men who have sex with men living with HIV: implications of assay variability.
Sex Transm Infect;
99(3): 187-190, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35545433
4.
Doravirine Concentrations and Human Immunodeficiency Virus Type 1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine Plus Emtricitabine/Tenofovir Alafenamide.
Clin Infect Dis;
75(11): 2012-2015, 2022 11 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35616112
5.
Total and Unbound Doravirine Concentrations and Viral Suppression in CSF.
Clin Infect Dis;
74(10): 1855-1858, 2022 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34549268
6.
Atherogenicity of low-density lipoproteins after switching from a protease inhibitor to dolutegravir: a substudy of the NEAT022 study.
J Antimicrob Chemother;
77(7): 1980-1988, 2022 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35411401
7.
Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters: results from a multicentre cohort study, 2004-2018.
BMC Infect Dis;
22(1): 379, 2022 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35428209
8.
No Changes in Human Immunodeficiency Virus (HIV) Suppression and Inflammatory Markers in Cerebrospinal Fluid in Patients Randomly Switched to Dolutegravir Plus Lamivudine (Spanish HIV/AIDS Research Network, PreEC/RIS 62).
J Infect Dis;
223(11): 1928-1933, 2021 06 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33049035
9.
Dynamics of the Decay of Human Immunodeficiency Virus (HIV) RNA and Distribution of Bictegravir in the Genital Tract and Rectum in Antiretroviral-naive Adults Living With HIV-1 Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS 58).
Clin Infect Dis;
73(7): e1991-e1999, 2021 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32945851
10.
Comparison of two sample collection devices for anal cytology in HIV-positive men who have sex with men: Cytology brush and Dacron swab.
Cytopathology;
32(5): 646-653, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34033168
11.
Total and Unbound Bictegravir Concentrations and Viral Suppression in Cerebrospinal Fluid of Human Immunodeficiency Virus-Infected Patients (Spanish HIV/AIDS Research Network, PreEC/RIS 56).
J Infect Dis;
221(9): 1425-1428, 2020 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31784745
12.
Seminal Tenofovir Concentrations, Viral Suppression, and Semen Quality With Tenofovir Alafenamide, Compared With Tenofovir Disoproxil Fumarate (Spanish HIV/AIDS Research Network, PreEC/RIS 40).
Clin Infect Dis;
69(8): 1403-1409, 2019 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30561517
13.
Bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection (GS-US-380-1489): a double-blind, multicentre, phase 3, randomised controlled non-inferiority trial.
Lancet;
390(10107): 2063-2072, 2017 Nov 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28867497
14.
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial.
Lancet;
390(10101): 1499-1510, 2017 Sep 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28750935
15.
Cerebrospinal fluid drug concentrations and viral suppression in HIV-1-infected patients receiving ritonavir-boosted atazanavir plus lamivudine dual antiretroviral therapy (Spanish HIV/AIDS Research Network, PreEC/RIS 39).
J Neurovirol;
24(4): 391-397, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29542028
16.
HIV-1-RNA Decay and Dolutegravir Concentrations in Semen of Patients Starting a First Antiretroviral Regimen.
J Infect Dis;
214(10): 1512-1519, 2016 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27578849
17.
Safe Reduction in CD4 Cell Count Monitoring in Stable, Virally Suppressed Patients With HIV Infection or HIV/Hepatitis C Virus Coinfection.
Clin Infect Dis;
62(12): 1578-1585, 2016 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27126346
18.
Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.
Lancet;
385(9987): 2606-15, 2015 Jun 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-25890673
19.
Effectiveness and safety of an abacavir/lamivudineâ+ârilpivirine regimen for the treatment of HIV-1 infection in naive patients.
J Antimicrob Chemother;
71(12): 3510-3514, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27591292
20.
Prediction of higher cost of antiretroviral therapy (ART) according to clinical complexity. A validated clinical index.
Enferm Infecc Microbiol Clin;
34(3): 149-58, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26298097